Institut des Matériaux Poreux de Paris - IMAP’s Post

🔬 Let's get deeper into the microbes: DNA and RNA are life bricks responsible for so many functions of the cell. 🧬 Molecular biology studies the structure and function of these molecules, as well as how genetic information is stored and expressed. Knowing how to and acting on these molecules have made it possible to develop new applications, such as the production of natural derived flavors and fragrances. #ecoinnovation #molecularbiology BGene Genetics

⏲ Tic, Tac, Tic, Tac ⏲ Time is running out Less than two days before the next webinar organized by Association NanoMesureFrance and hosted by Ineris - Institut national de l'environnement industriel et des risques. The subject❓ 👉 How to characterize the flammability 🔥 and explosibility 💥 of nanomaterials in the context of industrial risk assessment 🏭. And you know what 😉, this webinar is offered by one of the best experts in this field 👨🏫, it's completely free 🆓 and accessible to everyone!!! So don't hesitate any longer and register at the following link: https://lnkd.in/e9qTqU5Q #webinars #nanomaterials #explosion #risks

Let's talk about how motion analysis may revolutionise the paralympics at the annual congress of the SOFAMEA.

Yesterday, CDG Conseil attended the conference "safety medical devices/innovation" organised by the SNITEM at MAISON DE LA CHIMIE lead by the excellent speaker Thierry Watelet Stéphane Regnault (Snitem board member) and Marc-Pierre Möll (BV Med Managing Director) and Pieter Liese (European Deputy) commented with very good inputs the conference. Europe’s Medtech Industry: Challenges and Urgent Reforms in Brief Key Challenges 🌍Global Competition: U.S., China, and Japan innovate faster with fewer regulatory hurdles or try to adapt. 🚨Regulatory Burdens: Europe’s MDR delays and increases the cost of bringing products to market. 🚨Political Fragmentation: Diverging priorities across European nations hinder unified action. 🚨Innovation Decline: High costs and slow processes discourage small and medium enterprises (SMEs) to launch new products. - Simplify MDR processes to reduce time-to-market and costs. Boost public and private R&D investment in Medtech. - Promote collaboration between 👩⚕️stakeholders and👨💼 Foster political unity to streamline regulations. 🔆Moving Forward Reforming or adapt the new MDR and creating a supportive environment for innovation is vital to preserving Europe’s leadership in healthcare technology. Collaboration among political and industrial sectors will be essential to ensuring timely reforms that prioritize both innovation and patient safety. The time to act is now to secure the future of Europe’s Medtech industry and its impact on global healthcare. https://lnkd.in/eq5huxzd #CDGCONSEIL #Snitem #medicaldevices #innovation #MDR #europe

Curious about how synthetic biology is advancing cannabinoid production? Whether you’re from a scientific background or not, here are two insightful links that simplify and explain our latest research in this area. Dive in and discover how we’re leveraging biotech to make a difference! https://lnkd.in/ez3HJmN4 https://lnkd.in/eSQ-rzF9

𝗣𝗢𝗗𝗖𝗔𝗦𝗧 l 👉 𝐀𝐮𝐝𝐫𝐞𝐲 𝐏𝐡𝐚𝐧 is enrolled as a Ph.D. student at 𝐑𝐄𝐂𝐄𝐓𝐎𝐗, Masaryk University in Brno. 🐠 🔬 In the podcast bellow she speaks about her project linking retinoid and thyroid disruption with adverse effects during early development in zebrafish.

#Postdoc position:  "Preparation of micro/nanoparticle and/or fibrous matrices, based on natural polymers and their morphological and biofunctional characterization" materials science; biomedical engineering; pharmaceutical biotechnology; nanomaterials

🙏 Thanks to Institut de Biologie Structurale (IBS) for giving us the opportunity to present our concrete actions and results to reduce our total GHG emissions (scope 1, 2 and 3): -15% in 2 years while keeping a +50% growth! 👀 Watch José VIÑUELAS’ presentation 'Decarbonizing Preclinical R&D. Feedback session' here 👉 https://lnkd.in/eRfuSXdS   ♻ You can read more about genOway's Low-Carbon Program here 👉 https://lnkd.in/en6Tw9Fg   #genowaylowcarbon #preclinicalresearch #preclinicalservices

📋⚡️ We invite you to read the article where we have developed a carbon dots-based aptasensor 🧬 for detecting the pesticide chlorpyrifos in surface waters at various sites in Antioquia, Colombia 🇨🇴, as an outcome of Maria Isabel Gaviria, Ph.D’s doctoral thesis

🌟 A crucial step forward for HTL Biotechnology! Read the Les Echos article: https://lnkd.in/eps25yPQ We've therefore done it: very proud of our acquisition of the beauty and biomedical division of American company Modern Meadow and its human recombinant #collagen! While we already have a production unit under construction in Massachusetts, the acquisition of this innovative recombinant protein platform is an opportunity for us to strengthen our American innovation cluster. This acquisition will enable us to : 👊 Strengthen our position as global leader in pharmaceutical-grade biopolymers  🧬 Diversify our range with a broad and unique offering of biopolymers 💡 Innovate in our historical segments and in new therapeutic areas 🤝 Accelerate the innovation capabilities of our US and French teams through the complementarity and synergy of their expertise    🌿 Free ourselves from collagens of animal origin, for eco-responsible and vegan solutions.